Clinical observation on the effects of mifepristone and GnRH-a for postoperative pelvic endometriosis

In: Journal of Practical Diagnosis and Therapy · 2007 · W2385201947
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex
AI-generated summary by claude@2026-06, 2026-06-13

Mifepristone and gestrinone treatments after pelvic endometriosis surgery significantly lowered recurrence rates compared to no drug treatment, with mifepristone showing fewer adverse effects than gestrinone.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objective To study the effects and safety of mifepristone and GnRH-a for postoperative pelvic endometriosis.Methods Eighty-three pelvic endometriosis cases were analyzed retrospectively,in which 41 were given mifepristone(mifepristone group),15 were given gestrinone(gestrinone group) and other 27 cases didn't take any drugs(control group).Recurrence rate and adverse effect rate were compared among these groups.Results The recurrence rates of mifepristone group and GnRH-a group were 13.3% and 17.1%,respectively,significantly lower than that of control group(P0.05,P0.05).The adverse effect rate of mifepristone group was 14.6%,which was significantly lower than that of gestrinone group(66.7%)(P0.05).Conclusion Mifepristone and gestrinone are effective for postoperative pelvis endometriosis.Mifepristone has less adverse effects than that of gestrinone.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK